Zusammenfassung
Die stereotaktische Radiochirurgie (SRS) ist ein neurochirurgischer Arbeitsbereich, der zunehmend in der Behandlung von Akustikusneurinomen genutzt wird. Radiochirurgische Methoden sind das Gamma-Knife, die sog. LINAC-Technologie und das Cyberknife. Die Gamma-Knife-Radiochirurgie (GKRS) weist die größte Genauigkeit auf und wird seit Jahrzehnten bei Akustikusneurinomen eingesetzt (>18.000 Patienten). Im Unterschied zu chirurgischen Verfahren ist das Ziel der SRS eine Langzeitarretierung des Tumorwachstums bei Erhalt der neurologischen Funktion. Strahlenbedingte Neuropathien treten sehr selten auf. Die seit einigen Jahren verwendete fraktionierte stereotaktische Radiotherapie (FSR) weist wesentliche Unterschiede zur einzeitigen SRS bei radiobiologischer Wirksamkeit und Anwendung auf. Die SRS ist zumeist ambulant möglich. Neurinome bis zu 3 cm Größe sind mögliche Indikationen für SRS oder FSR. Größere Tumoren, Zysten und Neurinome mit Hirnstammkompression sollten wie bisher in erfahrenen Zentren (HNO oder Neurochirurgie) mikrochirurgisch reseziert werden. SRS (und FSR) sind ggf. als Option bei Patienten mit Tumorwachstum nach subtotaler Resektion oder Rezidivtumoren zu erwägen oder bei Patienten, die nicht operationstauglich oder -willig sind.
Abstract
Stereotactic radiosurgery (SRS) is a neurosurgical field that has become increasingly important in the treatment of acoustic neuromas. Radiosurgical treatment modalities include the Gamma knife, the linear accelerator (LINAC), and the CyberKnife. Gamma knife radiosurgery (GKRS) is still unsurpassed in terms of the spatial accuracy of radiation delivery and has been used for decades in acoustic neuromas (>18000 patients). In contrast to surgical resection, the goal of SRS is long-term prevention of tumour growth with preservation of neurological function. Radiation-induced neuropathies rarely occur. However, there are essential differences between SRS and fractionated stereotactic radiotherapy (FSR) in terms of both their radiobiological effects and their modes of application. SRS can be performed in an outpatient setting. Neuromas of up to 3 cm in diameter represent potential candidates for SRS or FSR. For larger tumours, cystic lesions and neuromas with brain stem compression, microsurgical resection in experienced neurosurgical centres is still the preferred option. SRS (and FSR) are possible options for patients with tumour progression after subtotal surgery or tumour recurrence, or for patients unable or unwilling to undergo surgery.
Literatur
Bance M, Guha A (2001) Radiation induced malignant tumors after stereotactic radiosurgery. Otol Neurotol 22:124–125
Barnett GH, Linskey ME, Adler JR et al (2007) Stereotactic radiosurgery – an organized neurosurgery-sanctioned definition. J Neurosurg 106:1–5
Baser ME, Evans DGR, Jackler RK et al (2000) Neurofibromatosis 2, radiosurgery and malignant nervous system tumours. Br J Cancer 82:998
Battaglia A, Mastrodimos B, Cueva R (2006) Comparison of growth patterns of acoustic neuromas with and without radiosurgery. Otol Neurotol 27:705–712
Brackmann DE, Owens RM, Friedman RA et al (2000) Prognostic factors for hearing preservation in vestibular schwannoma surgery. Am J Otol 21:417–424
British Association of Otorhinolaryngologists, Head and Neck Surgeons (2002) Clinical effectiveness guidelines acoustic neuroma (vestibular schwannoma). BAO-HNS Document 5, Spring 2002
Chan AW, Black P, Ojemann RG et al (2005) Stereotactic radiotherapy for vestibular schwannomas: favorable outcome with minimal toxicity. Neurosurgery 57:60–70
Charabi S, Thomsen J, Mantoni M et al (1995) Acoustic neuroma (vestibular schwannoma): growth and surgical and nonsurgical consequences of the wait-and-see policy. Otolaryngol Head Neck Surg 113:5–14
Chopra R, Kondziolka D, Niranjan A et al (2007) Long-term follow-up of acoustic schwannoma radiosurgery with marginal tumor doses of 12 to 13 Gy. Int J Radiat Oncol Biol Phys 68:845–851
Clifford W, Sharpe H, Khu KJ et al (2009) Gamma Knife patients‘ experience: lessons learned from a qualitative study. J Neurooncol 92:387–392
Comey CH, McLaughlin MR, Jho HD et al (1998) Death from a malignant cerebellopontine angle triton tumour despite stereotactic radiosurgery. J Neurosurg 89:653–658
Flickinger JC, Kondziolka D, Lunsford LD (1996) Dose and diameter relationships for facial, trigeminal, and acoustic neuropathies following acoustic neuroma radiosurgery. Radiother Oncol 41:215–219
Flickinger JC, Kondziolka D, Lunsford LD (1999) Dose selection in stereotactic radiosurgery. Neurosurg Clin N Am 10:271–280
Flickinger JC, Kondziolka D, Niranjan A, Lunsford LD (2001) Results of acoustic neuroma radiosurgery: an analysis of 5 years‘ experience using current methods. J Neurosurg 94:1–6
Fukuoka S, Takanashi M, Hojyo A et al (2009) Gamma knife radiosurgery for vestibular schwannomas. In: Yamamoto M (Hrsg) Japanese experience with gamma knife radiosurgery. Prog Neurol Surg 22:45–62
Gardner G, Robertson JH (1988) Hearing preservation in unilateral acoustic neuroma surgery. Ann Otol Rhinol Laryngol 97:55–66
Grossauer S (2004) Die Nebenwirkungen der Gamma-Knife-Therapie bei der Behandlung von Akustikusneurinomen. Dissertation, Medizinische Fakultät, Karl-Franzens-Universität Graz
Haselsberger K, Maier T, Dominikus K et al (2009) Staged gamma knife radiosurgery for large critically located benign meningiomas: evaluation of a series comprising 20 patients. J Neurol Neurosurg Psychiatry 80:1172–1175
House JW, Brackmann DE (1985) Facial nerve grading system. Otolaryngol Head Neck Surg 93:146–147
Iwai Y, Yamanaka K, Shiorani M, Uyama T (2003) Radiosurgery for acoustic neuromas: results of low-dose treatment. Neurosurgery 53:282–287
Karpinos M, Teh BS, Zeck O et al (2002) Treatment of acoustic neuroma: stereotactic radiosurgery vs. microsurgery. Int J Radiat Oncol Biol Phys 54:1410–1421
Kida Y, Kobayashi T, Tanaka T, Mori Y (2000) Radiosurgery for bilateral neurinomas associated with neurofibromatosis type 2. Surg Neurol 53:383–390
Kondziolka D, Lunsford LD, McLaughlin MR, Flickinger JC (1998) Long-term outcomes after radiosurgery for acoustic neuromas. N Engl J Med 339:1426–1433
Kondziolka D, Lunsford LD, Witt TC, Flickinger JC (2000) The future of radiosurgery: radiobiology, technology and applications. Surg Neurol 54:406–414
Larson DA, Flickinger JC, Loeffler JS (1993) The radiobiology of radiosurgery. Int J Radiat Oncol Biol Phys 25:557–561
Linskey ME (2008) Hearing preservation in vestibular schwannoma stereotactic radiosurgery: what really matters? J Neurosurg 109(Suppl):129–136
Linskey ME, Flickinger JC, Lunsford LD (1993) Cranial nerve length predicts the risk of delayed facial and trigeminal neuropathies after acoustic tumour stereotactic radiosurgery. Int J Radiat Oncol Biol Phys 25:227–233
Luppino FS, Grooters E, Bruine FT de et al (2006) Volumetrical measurements in vestibular schwannoma, the influence of slice thickness and patient’s repositioning. Otol Neurotol 27:962–968
Maire JP, Huchet A, Milbeo Y et al (2006) Twenty years‘ experience in the treatment of acoustic neuromas with fractionated radiotherapy: a review of 45 cases. Int J Radiat Oncol Biol Phys 66:170–178
Mann W, Gouveris HAT (2009) Diagnosis and therapy of vestibular schwannoma. Expert Rev Neurother 9:1219–1232
Meeks SL, Buatti JM, Foote KD et al (2000) Calculation of cranial nerve complication probability for acoustic neuroma radiosurgery. Int J Radiat Oncol Biol Phys 47:597–602
Meijer OW, Weijmans EJ, Knol DL et al (2008) Tumor-volume changes after radiosurgery for vestibular schwannoma: implications for follow-up MR imaging protocol. AJNR Am J Neuroradiol 29:906–910
Müller S, Arnolds J, Oosterhout A van (2010) Decision-making of vestibular schwannoma patients. Acta Neurochir 152:973–984
Niranjan A, Mathieu D, Flickinger JC et al (2008) Hearing preservation after intracanalicular vestibular schannoma radiosurgery. Neurosurgery 63:1054–1062
Ottaviani F, Neglia CB, Ventrella L et al (2002) Hearing loss and changes in transient evoked otoacoustic emissions after gamma knife radiosurgery for acoustic neurinomas. Arch Otolaryngol Head Neck Surg 128:1308–1312
Ott K (1996) A comparison of craniotomy and gamma knife charges in a community-based gamma knife centre. Stereotact Funct Neurosurg 66(Suppl 1):357–364
Paddick I (2000) A simple scoring ratio to index the conformity of radiosurgical treatment plans. J Neurosurg 93(Suppl 3):219–222
Paek SH, Chung HT, Jeong SS et al (2005) Hearing preservation after gamma knife stereotactic radiosurgery of vestibular schwannoma. Cancer 104:580–590
Pendl G, Unger F, Papaefthymiou G, Eustacchio S (2000) Staged radiosurgical treatment for large benign cerebral lesions. J Neurosurg 93(Suppl 3):107–112
Pollock BE, Driscoll CL, Foote RL et al (2006) Patient outcomes after vestibular schwannoma management: a prospective comparison of microsurgical resection and stereotactic radiosurgery. Neurosurgery 59:77–85
Pollock BE, Lunsford LD, Kondziolka D et al (1995) Outcome analysis of acoustic neuroma management: a comparison of microsurgery and stereotactic radiosurgery. Neurosurgery 36:215–229
Régis J, Tamura M, Delsanti C et al (2008) Hearing preservation in patients with unilateral vestibular schwannoma after gamma knife surgery. Prog Neurol Surg 21:142–151
Ron E, Modan B, Boice JD Jr et al (1988) Tumors of the brain and nervous system after radiotherapy in childhood. N Engl J Med 319:1033–1039
Samii M, Matthies C (1997) Management of 1000 vestibular schwannomas (acoustic neuromas): surgical management and results with an emphasis on complications and how to avoid them. Neurosurgery 40:11–21
Samii M, Matthies C (1997) Management of 1000 vestibular schwannomas (acoustic neuromas): hearing function in 1000 tumour resections. Neurosurgery 40:248–262
Shamisa A, Bance M, Nag S et al (2001) Glioblastoma multiforme occurring in a patient treated with gamma knife radiosurgery. Case report and review of literature. J Neurosurg 94:816–821
Slattery WH III, Brackmann DE (1995) Results of surgery following stereotactic irradiation for acoustic neuromas. Am J Otol 16:315–321
Tan M, Myrie OA, Lin FR et al (2010) Trends in the management of vestibular schwannomas at Johns Hopkins 1997–2007. Laryngoscope 120:144–149
Thomas C, Di Maio S, Ma R et al (2007) Hearing preservation following fractionated stereotactic radiotherapy for vestibular schwannomas: prognostic implications of cochlear dose. J Neurosurg 107:917–926
Thomsen J, Mirz F, Wetke R et al (2000) Intracranial sarcoma in a patient with neurofibromatosis type 2 treated with gamma knife radiosurgery for vestibular schwannoma. Am J Otol 21:364–370
Unger F, Walch C, Papaefthymiou G et al (2002) Radiosurgery of residual and recurrent vestibular schwannomas. Acta Neurochir (Wien) 144:671–677
Unger F, Walch C, Papaefthymiou G et al (1999) Die Radiochirurgie des Akustikusneurinoms als minimal-invasive Alternative zur Mikrochirurgie. HNO 47:1046–1051
Unger F, Walch C, Schröttner O et al (2002) Cranial nerve preservation after radiosurgery of vestibular schwannomas. Acta Neurochir (Suppl 84):77–83
Roijen L van, Nijs HG, Avezaat CJ et al (1997) Costs and effects of microsurgery versus radiosurgery in treating acoustic neuroma. Acta Neurochir 139:942–945
Wiegand DA, Fickel V (1989) Acoustic neuroma – the patient’s perspective: subjective assessment of symptoms, diagnosis, therapy, and outcome in 541 patients. Laryngoscope 99:179–187
Williams JA (2002) Fractionated stereotactic radiotherapy for acoustic neuromas. Stereotact Funct Neurosurg 78:17–28
Yamasoba T, Kurita H, Ito K et al (1996) Auditory findings after stereotactic radiosurgery in acoustic neurinoma. Skull Base Surg 6:163–167
Danksagung
Abb. 1, Abb. 2 und Abb. 3 wurden freundlicherweise zur Verfügung gestellt von Elekta AB, Stockholm, Schweden. Die Autoren danken Frau Elfriede Meier für die Hilfe bei der Erstellung des Manuskripts.
Interessenkonflikt
Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Unger, F., Dominikus, K. & Haselsberger, K. Stereotaktische Radiochirurgie und Radiotherapie bei Akustikusneurinomen. HNO 59, 31–37 (2011). https://doi.org/10.1007/s00106-010-2191-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00106-010-2191-x